Guardant Health (GH) Sees 48% Growth as Its Cancer Tests Gain Momentum

Reported by Yahoo Finance · Published 5 Aug 2026, 8:31 PM MYT (3 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says 41 min ago 3 money rules I swear by — and why they work 54 min ago Could Centene (CNC) Be Entering a Major Margin Recovery? 55 min ago Strategy’s STRC rebounds 30% as company builds cash reserve, bitcoin price stabilizes 56 min ago It’s the worst time in years to invest in AI credit markets: ‘Almost no upside and plenty of downside’ 56 min ago Equifax’s (EFX) Essential Datasets Drive Consistent Growth 57 min ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Guardant Health (GH) Sees 48% Growth as Its Cancer Tests Gain Momentum

Summary

More in Markets

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

3 money rules I swear by — and why they work

Could Centene (CNC) Be Entering a Major Margin Recovery?

It’s the worst time in years to invest in AI credit markets: ‘Almost no upside and plenty of downside’

Equifax’s (EFX) Essential Datasets Drive Consistent Growth

Elon Musk's Tesla and SpaceX Have Shed $1.19 Trillion in Value Since June. Is This a Buying Opportunity?